| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut National de la Santé et de la Recherche Médicale, Unité 773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, and Université Paris 7 Denis Diderot, site Bichat, F-75018, Paris, France
Address all correspondence and requests for reprints to: Thierry Voisin, Institut National de la Santé et de la Recherche Médicale, Unité 773, Centre de Recherche Biomédicale Bichat Beaujon CRB3, BP 416, F-75018, Paris, France; Université Paris 7 Denis Diderot, site Bichat, BP 416, F-75018, Paris, France. E-mail: tvoisin{at}bichat.inserm.fr.
Orexin-A and orexin-B are regulatory peptides involved in the control of feeding, sleep-wakefulness, and exerting various endocrine and metabolic actions. Recently we demonstrated that orexins, acting at OX1 receptor (OX1R), are proapoptotic peptides. The aim of this study was to investigate the role of the receptor subtype OX2R in the control of apoptosis. Orexins caused a caspase-dependent cell death by apoptosis and a drastic cell growth inhibition in Chinese hamster ovary cells transfected with OX2R cDNA. On addition of either orexin (10–6 M) for 48 h, apoptosis was demonstrated by DNA fragmentation, chromatin condensation, annexin-V binding, and activation of caspase-3 and caspase-9. Orexins were active on apoptosis and cell growth inhibition in the range of concentrations between 10–10 and 10–5 M with an EC50 of 5 x 10–8 M peptides. No effect of orexins could be detected in parental Chinese hamster ovary cells. A rat pancreatic acinar cell line, AR42J, which expresses OX2R but not OX1R, also underwent growth suppression and apoptosis on treatment with orexins. Suppression of AR42J cell growth by 10–6 M orexin was more than 75% after 24 h. Induction of annexin-V-labeled AR42J cell number was dose dependent, with EC50 of 5.1 x 10–8 M orexin-A and 9.8 x 10–8 M orexin-B. The OX2R agonist [Ala (11), D-Leu (15)]orexin-B promoted effects on cell growth and apoptosis, which were similar to those elicited by orexins. The OX1R antagonist SB33487 did not alter orexin-induced inhibition of growth or orexin-induced stimulation of apoptosis in AR42J cells. For the first time, we provide functional and pharmacological evidence for a role of the OX2R in orexin-induced apoptosis.
This article has been cited by other articles:
 |
|
 |
|
  M. Ramanjaneya, A. C Conner, J. Chen, P. Kumar, J. E P Brown, O. Johren, H. Lehnert, P. R Stanfield, and H. S Randeva Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B J. Endocrinol., August 1, 2009; 202(2): 249 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D'Amora, T. T. Maciel, R. Tambellini, M. A. Mori, J. B. Pesquero, H. Sato, M. J. B. C. Girao, I. D. C. Guerreiro da Silva, and E. Schor Disrupted Cell Cycle Control in Cultured Endometrial Cells from Patients with Endometriosis Harboring the Progesterone Receptor Polymorphism PROGINS Am. J. Pathol., July 1, 2009; 175(1): 215 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H Marino, C. Tan, B. Davis, E.-S. Han, M. Hickey, R. Naukam, A. Taylor, K. S Miller, C J. Van De Wiele, and T K. Teague Disruption of thymopoiesis in ST6Gal I-deficient mice Glycobiology, September 1, 2008; 18(9): 719 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Voisin, A. El Firar, C. Rouyer-Fessard, V. Gratio, and M. Laburthe A hallmark of immunoreceptor, the tyrosine-based inhibitory motif ITIM, is present in the G protein-coupled receptor OX1R for orexins and drives apoptosis: a novel mechanism FASEB J, June 1, 2008; 22(6): 1993 - 2002. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
